Dr. Rudloff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Center For Cancer Research Ccr Nci Nih
Hatfield Center, Room 4-5940, 10 Center Drive
Bethesda, MD 20892Phone+1 301-496-3098Fax+1 301-402-1788
Education & Training
- NYU Grossman School of MedicineResidency, Surgery, 2005 - 2007
- University of Heidelberg Faculty of MedicineClass of 1997
Certifications & Licensure
- VA State Medical License 2013 - 2026
- MD State Medical License 2018 - 2025
- NM State Medical License 2007 - 2014
- American Board of Surgery Surgery
Clinical Trials
- Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study Start of enrollment: 2004 Dec 21
- The Natural History of Solid Organ Cancer Stem Cells (SOCSC) Start of enrollment: 2009 Feb 09
- Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial Start of enrollment: 2009 Jul 22
- Join now to see all
Publications & Presentations
PubMed
- 199 citationsMannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responsesJesse M. Jaynes, Rushikesh Sable, Michael Ronzetti, Wendy Bautista, Zachary Knotts
Science Translational Medicine. 2020-02-12 - 18 citationsWhole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of P...Rebecca Sorber, Yaroslav Teper, Abisola Abisoye-Ogunniyan, Joshua J. Waterfall, Sean Davis
Plos One. 2016-03-10 - 28 citationsAn integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancerJinping Jia, Hemang Parikh, Wenming Xiao, Jason W. Hoskins, Holger Pflicke
BMC Medical Genomics. 2013-09-22
Press Mentions
- Mini-Review: PDPK1 (3-Phosphoinositide Dependent Protein Kinase-1), an Emerging Cancer Stem Cell TargetApril 12th, 2021
- Combining the Antimesothelin Immunotoxin SS1P with the BH3-Mimetic ABT-737 Induces Cell Death in SS1P-Resistant Pancreatic Cancer CellsNovember 16th, 2020
- Tumor Testing May Help Guide Pancreatic Cancer TreatmentApril 16th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: